Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX? - Endpoints News
Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX? Endpoints News
As is standard practice, Tasly did not pin a figure on their pitch, though previous reports have suggested goals around $1 billion — the amount that Hansoh ...
Comments
Post a Comment